Gemcitabine in the treatment of refractory Hodgkin's disease: results of a multicenter phase II study.
Santoro A, Bredenfeld H, Devizzi L, Tesch H, Bonfante V, Viviani S, Fiedler F, Parra HS, Benoehr C, Pacini M, Bonadonna G, Diehl V.
Santoro A, et al. Among authors: bonfante v.
J Clin Oncol. 2000 Jul;18(13):2615-9. doi: 10.1200/JCO.2000.18.13.2615.
J Clin Oncol. 2000.
PMID: 10893294
Clinical Trial.